dc.contributor.author |
Budeanu, Razvan-Gabriel |
|
dc.contributor.author |
Jugariu, Anamaria-Romina |
|
dc.contributor.author |
Katona, Timea |
|
dc.contributor.author |
Baetu, Alexandru Emil |
|
dc.contributor.author |
Lates, Gratiana-Andreea |
|
dc.date.accessioned |
2020-07-02T14:25:55Z |
|
dc.date.available |
2020-07-02T14:25:55Z |
|
dc.date.issued |
2018 |
|
dc.identifier.citation |
BUDEANU, Razvan-Gabriel, JUGARIU, Anamaria-Romina, KATONA, Timea, BAETU, Alexandru Emil, LATES, Gratiana-Andreea. Treatment of chronic lymphocytic leukemia – a difficult choice for severe complications: a case report. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 27. |
en_US |
dc.identifier.uri |
https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf |
|
dc.identifier.uri |
http://repository.usmf.md/handle/20.500.12710/10854 |
|
dc.description |
University of Medicine and Pharmacy of Targu Mures |
en_US |
dc.description.abstract |
Background. Chronic lymphocytic leukemia (CLL) is the most common form of adult leukemia
in the western European countries and is characterized by the relentless accumulation of
monoclonal B cells with the appearance of small mature lymphocytes and with a characteristic
immunophenotype. Even with the right treatment, this disease is known to have a variable
course: some patients die within one year after diagnosis while others live for longer than ten
years. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
MedEspera |
en_US |
dc.subject |
chronic lymphocytic leukemia |
en_US |
dc.subject |
treatment |
en_US |
dc.subject |
drug selection |
en_US |
dc.subject |
side effects |
en_US |
dc.title |
Treatment of chronic lymphocytic leukemia – a difficult choice for severe complications: a case report |
en_US |
dc.type |
Article |
en_US |